These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32917539)

  • 1. First-Trimester Preterm Preeclampsia Screening in Nulliparous Women: The Great Obstetrical Syndrome (GOS) Study.
    Boutin A; Gasse C; Guerby P; Giguère Y; Tétu A; Bujold E
    J Obstet Gynaecol Can; 2021 Jan; 43(1):43-49. PubMed ID: 32917539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.
    Boutin A; Guerby P; Gasse C; Tapp S; Bujold E
    Am J Obstet Gynecol; 2021 Feb; 224(2):204.e1-204.e7. PubMed ID: 32777265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
    Pihl K; Sørensen S; Stener Jørgensen F
    Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population.
    Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC
    Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of first-trimester combined screening for preterm pre-eclampsia: findings from cohort of 10 110 pregnancies in Spain.
    Cuenca-Gómez D; de Paco Matallana C; Rolle V; Valiño N; Revello R; Adiego B; Mendoza M; Molina FS; Carrillo MP; Delgado JL; Wright A; Santacruz B; Gil MM
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):522-530. PubMed ID: 37099759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Trimester Uterine Artery Doppler for the Prediction of SGA at Birth: The Great Obstetrical Syndromes Study.
    Drouin O; Boutin A; Paquette K; Gasse C; Guerby P; Demers S; Bujold E
    J Obstet Gynaecol Can; 2018 Dec; 40(12):1592-1599. PubMed ID: 30314872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of spontaneous preterm birth and preterm prelabor rupture of membranes using maternal factors, obstetric history and biomarkers of placental function at 11-13 weeks.
    Chiu CPH; Feng Q; Chaemsaithong P; Sahota DS; Lau YY; Yeung YK; Yim LW; Chung JPW; Poon LC
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):192-199. PubMed ID: 35445767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
    Tan MY; Syngelaki A; Poon LC; Rolnik DL; O'Gorman N; Delgado JL; Akolekar R; Konstantinidou L; Tsavdaridou M; Galeva S; Ajdacka U; Molina FS; Persico N; Jani JC; Plasencia W; Greco E; Papaioannou G; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Aug; 52(2):186-195. PubMed ID: 29896812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment.
    Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH
    BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPRE trial: risk factors for development of preterm pre-eclampsia despite aspirin prophylaxis.
    Shen L; Martinez-Portilla RJ; Rolnik DL; Poon LC
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):546-552. PubMed ID: 33998099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-Trimester Uterine Artery Doppler for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndrome Study.
    Demers S; Boutin A; Gasse C; Drouin O; Girard M; Bujold E
    Am J Perinatol; 2019 Jul; 36(9):930-935. PubMed ID: 30414599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-Trimester Placental Growth Factor for the Prediction of Preeclampsia in Nulliparous Women: The Great Obstetrical Syndromes Cohort Study.
    Boutin A; Demers S; Gasse C; Giguère Y; Tétu A; Laforest G; Bujold E
    Fetal Diagn Ther; 2019; 45(2):69-75. PubMed ID: 30304731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
    Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between adverse pregnancy outcome and placental biomarkers in the first trimester: A prospective cohort study.
    Sovio U; Gaccioli F; Cook E; Charnock-Jones DS; Smith GCS
    BJOG; 2024 May; 131(6):823-831. PubMed ID: 37822261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective Validation of First-Trimester Screening for Preterm Preeclampsia in Nulliparous Women (PREDICTION Study).
    Guerby P; Audibert F; Johnson JA; Okun N; Giguère Y; Forest JC; Chaillet N; Mâsse B; Wright D; Ghesquiere L; Bujold E
    Hypertension; 2024 Jul; 81(7):1574-1582. PubMed ID: 38708601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
    Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
    Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
    BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.